Hexagon Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75	Closed	-$7.59K	–	1466
2023 Q1	$7.59K	Buy	75 +5	+7%	+$506	﹤0.01%	800
2022 Q4	$8.36K	Sell	70 -25	-26%	-$2.99K	﹤0.01%	770
2022 Q3	$10K	Buy	+95	New	+$10K	﹤0.01%	774